JHS Svendgaard Laboratories Limited (JHS.NS)
INR 22.38
(0.41%)
INR 22.38
(0.41%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 51.28 Million INR | 47.87% |
| 2022 | 34.68 Million INR | -43.89% |
| 2021 | 61.81 Million INR | -11.83% |
| 2020 | 70.11 Million INR | -18.35% |
| 2019 | 85.86 Million INR | 19.43% |
| 2018 | 71.89 Million INR | 188.46% |
| 2017 | 24.92 Million INR | 12.13% |
| 2016 | 22.22 Million INR | 60.66% |
| 2015 | 13.83 Million INR | -92.59% |
| 2014 | 186.66 Million INR | -59.53% |
| 2013 | 461.25 Million INR | -39.23% |
| 2012 | 758.99 Million INR | 184.39% |
| 2011 | 266.88 Million INR | -43.84% |
| 2010 | 475.23 Million INR | 14.75% |
| 2009 | 414.16 Million INR | -15.32% |
| 2008 | 489.07 Million INR | 47.01% |
| 2007 | 332.69 Million INR | 202.48% |
| 2006 | 109.98 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 51.28 Million INR | 0.0% |
| 2023 Q2 | 23.29 Million INR | 0.0% |
| 2023 FY | 51.28 Million INR | 47.87% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 34.68 Million INR | -43.89% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 64.3 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 34.68 Million INR | 0.0% |
| 2021 Q2 | 60.7 Million INR | 0.0% |
| 2021 Q4 | 61.81 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 61.81 Million INR | -11.83% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 77.28 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 70.11 Million INR | 0.0% |
| 2020 FY | 70.11 Million INR | -18.35% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 75.07 Million INR | 0.0% |
| 2019 FY | 85.86 Million INR | 19.43% |
| 2019 Q4 | 85.86 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 56.3 Million INR | 0.0% |
| 2018 FY | 71.89 Million INR | 188.46% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 71.89 Million INR | 0.0% |
| 2017 FY | 24.92 Million INR | 12.13% |
| 2017 Q2 | 10.78 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 24.92 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 7.44 Million INR | 0.0% |
| 2016 FY | 22.22 Million INR | 60.66% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 15.52 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q2 | 212.59 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 13.83 Million INR | 0.0% |
| 2015 FY | 13.83 Million INR | -92.59% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q2 | 434.36 Million INR | 0.0% |
| 2014 FY | 186.66 Million INR | -59.53% |
| 2014 Q4 | 186.66 Million INR | 0.0% |
| 2013 Q2 | 689.81 Million INR | 0.0% |
| 2013 Q4 | 995.53 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 461.25 Million INR | -39.23% |
| 2012 Q2 | 631.92 Million INR | 0.0% |
| 2012 FY | 758.99 Million INR | 184.39% |
| 2012 Q4 | 758.99 Million INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2011 FY | 266.88 Million INR | -43.84% |
| 2010 FY | 475.23 Million INR | 14.75% |
| 2009 FY | 414.16 Million INR | -15.32% |
| 2008 FY | 489.07 Million INR | 47.01% |
| 2007 FY | 332.69 Million INR | 202.48% |
| 2006 FY | 109.98 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ambica Agarbathies Aroma & Industries Limited | 673.21 Million INR | 92.382% |
| Bajaj Consumer Care Limited | 87.51 Million INR | 41.393% |
| BCL Industries Limited | 4.77 Billion INR | 98.925% |
| Colgate-Palmolive (India) Limited | 717.5 Million INR | 92.852% |
| Cupid Limited | 120.58 Million INR | 57.468% |
| Dabur India Limited | 13.65 Billion INR | 99.624% |
| Emami Limited | 939.5 Million INR | 94.541% |
| Gillette India Limited | 500 Thousand INR | -10157.4% |
| Godrej Consumer Products Limited | 32.22 Billion INR | 99.841% |
| Hindustan Unilever Limited | 14.84 Billion INR | 99.654% |
| Honasa Consumer Limited | 1.3 Billion INR | 96.084% |
| Jyothy Labs Limited | 505.6 Million INR | 89.856% |
| Kaya Limited | 3.01 Billion INR | 98.299% |
| Marico Limited | 5.28 Billion INR | 99.029% |
| N.K Industries Limited | - INR | -Infinity% |
| Procter & Gamble Hygiene and Health Care Limited | 30.8 Million INR | -66.516% |
| S H Kelkar and Company Limited | 6.65 Billion INR | 99.23% |